Furthermore, Kuzu et al. reported that leelamine, an inhibitor of cholesterol egress from lysosomes, reduced cholesterol levels in all membrane-bound organelles in cancer cells and suppressed NF-κB activation via the Akt signaling pathway47. Here, NFKB1 is linked to cancer.